12 Jun Presenting at Global Innovation in Women’s Health Pitch Showcase
Montreal / June 11, 2026
NexPlasmaGen is honored to be selected to pitch in person at this important event for women and for healthcare in San Diego June 21!
If you are in San Diego, let’s meet!
🌸🌸This is the Premier Women’s Health Pitch Competition where leading entrepreneurs, investors, and innovators unite to transform women’s healthcare during the BIO International week 2026.
The event is a dynamic pitch showcase aimed at discovering and supporting groundbreaking solutions that address critical issues in women’s health. By bringing together innovators, researchers, and entrepreneurs from around the globe, this event seeks to accelerate advancements in areas such as reproductive health, mental well-being, and chronic disease management. Participants will have the opportunity to showcase their ideas, gain valuable mentorship, and compete for prizes, all while contributing to the improvement of women’s health outcomes worldwide.
ABOUT NEXPLASMAGEN
NexPlasmaGen converges the emerging field of cold plasma biotechnology towards personalized cancer treatment. We develop high-precision cold plasma systems that destroy cancer cells while sparing the healthy tissue. The first application of NexPlasmaGen is the treatment of breast cancer, followed by skin and lung cancer. Its patented cold plasma medical device has the potential to reduce the rate of cancer recurrence as well as side effects and toxicity of the standard of care for the benefit of patients.
Contact :
Dr. Valérie Léveillé, ing., M.Sc.A., CEO/Founder
Tel. : 1-514-229-9458
Email : valerie.leveille@nexplasmagen.com
Website : https://nexplasmagen.com/
No Comments